Physician profile
William L Rice
NPI 1598735177
$693.33
in general payments reported to CMS, 2019-2025
10 companies · $47.94 in 2025
The $47.94 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.08 · 2021: $22.79 · 2022: $206 · 2023: $321 · 2024: $83.04 · 2025: $47.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $179.50 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Polynovo North America LLC | $152.11 | 2023 | |
| Smith+Nephew, INC. | $86.74 | 2022-2023 | Pico, Renasys Go V2 Home |
| Zimmer Biomet Holdings, INC. | $84.41 | 2022 | |
| Amgen INC. | $52.64 | 2020-2023 | Evenity, Prolia |
| Pfizer INC. | $51.56 | 2024 | |
| Kerecis Limited | $28.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $24.92 | 2023 | Puraply |
| Ethicon US, LLC | $20.28 | 2023 | Stratafix |
| Reprise Biomedical, INC. | $12.72 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.